IO-108,pembrolizumab,cemiplimab 
Immune-Onc Therapeutics,Merck,Regeneron
['io-108', 'solid tumor', 'pembro']
aacr23: phase 1 trial of io-108, an antagonist antibody targeting lilrb2 (ilt4), as monotherapy and in combination with pembrolizumab in adult patients with advanced relapsed or refractory solid tumors 
FirmaMasks can help protect during the Covid-19. Manufactured in Canada. Shop online: https://t.co/1nRpUV4Th2